Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06500988 · ClinicalTrials.gov registry record · NA
Mobile Health Technology-Enabled AFib Management
A NA study of Atrial Fibrillation and Behavior, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 2
- Study locations
NCT06500988: Recruiting NA study of Atrial Fibrillation and Behavior, sponsored by Johns Hopkins University.
NCT06500988 is a NA study of Atrial Fibrillation and Behavior that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 248 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06500988, a NA study of Atrial Fibrillation and Behavior, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall objective of this proposal is to evaluate the effect on quality of life of a comprehensive digital atrial fibrillation (AFib) management tool that will empower patients to a) take an active role in learning about AFib management options, starting and adhering to evidence-based therapies and lifestyle changes and b) to guide the patients during AFib episodes which are associated with anxiety and impairment in quality of life. Researchers plan to evaluate the effectiveness of this novel digital toolkit in improving quality of life and decreasing AFib burden in a randomized clinical trial (RCT). A pilot study assessing feasibility and retention of the intervention was previously conducted (NCT05400837)
Primary Outcome
Freedom from documented atrial tachyarrhythmia (atrial fibrillation/atrial flutter/atrial tachycardia) episodes of ≥30 seconds between 91 and 365 days after catheter ablation, on or off antiarrhythmic drugs.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Corrie Virtual Atrial Fibrillation Management Program
Study Locations (2)
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
- Johns Hopkins Outpatient Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2025-06-03 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT06500988 shows while recruiting
NCT06500988 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Corrie Virtual Atrial Fibrillation Management Program is the first listed.
NCT06500988 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06500988 about?
NCT06500988 is a clinical study titled "Mobile Health Technology-Enabled AFib Management". The overall objective of this proposal is to evaluate the effect on quality of life of a comprehensive digital atrial fibrillation (AFib) management tool that will empower patients to a) take an active role in learning about AFib management options, starting and adhering to evidence-based therapies ...
What is the current status of trial NCT06500988?
This trial is currently recruiting. It is a NA study. The enrollment target is 248 participants. The study started on 2025-06-03. Estimated completion is 2028-06.
What conditions does trial NCT06500988 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Behavior.
What interventions are being tested in trial NCT06500988?
The interventions under investigation include: Corrie Virtual Atrial Fibrillation Management Program (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06500988?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06500988 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06500988's enrollment target sits among peer trials
248 93rd of 202 higher than 110 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI